Facilities

XEPTAGEN is situated at the VEGA Science Park in Venice, Italy. The center is dedicated to the development of nano-biotechnology applications in molecular oncology and R&D processes for drug discovery. Strong investments have equipped the facility with state of the art technology and the most up-to-date equipment for high-throughput protein screening and for developing latest generation diagnostic devices and therapeutics in oncology.
XEPTAGEN shares a strong expertise in molecular oncology, Combinatorial Proteomic®, combinatorial chemistry, biochemistry and molecular immunology. In addition, extensive experience is available on production, purification and characterization of monoclonal and polyclonal antibodies.

Research Capabilities

• Peptide synthesis and purification
• Recombinant protein production and purification
• Monoclonal antibody production and purification
• Polyclonal antibody production and purification
• ELISA: Assay development
• Assay of gene expression
• High-throughput gene mutation scanning
• High-throughput polymorphism screening
• Biomarker discovery
• Combinatorial Chemistry
• Proteomics
• Combinatorial proteomic
• Molecular toxicology